Notified Blog

10 Popular Journalists Covering Biotech and Pharmaceuticals

In this blog, we feature reporters covering biotech and pharmaceuticals who are known for their wide reach, high readership and online visibility – and are all found within our media contacts database.

Whether you’re announcing a groundbreaking drug, highlighting clinical trial results or sharing insights on industry trends, these journalists should definitely be on your radar. 

10 Popular Journalists Covering Biotech and Pharmaceuticals

 

10 Popular Journalists Covering Biotech and Pharma

Adam Feuerstein - STAT (Boston, MA) 

Adam is a senior writer at STAT, covering biotech, pharma and Wall Street. Known for his sharp analysis and investigative reporting, he breaks down clinical trials, FDA decisions and industry deals.  

He also co-hosts STAT’s The Readout LOUD podcast and writes Adam’s Biotech Scorecard newsletter. His award-winning work has shaped major conversations in biotech. 

Contact: LinkedIn, X (117k+ followers)

Jared S. Hopkins - The Wall Street Journal (New York, NY) 

Jared is a healthcare reporter for The Wall Street Journal, covering topics like drug pricing, patent disputes and pharmaceutical trends. 

His recent articles explore how Medicare pays different prices for the same drug, legal battles over Merck’s cancer drug Keytruda and how drugmakers are handling price increases. He covers important challenges in the pharmaceutical industry and how they shape healthcare. 

Contact: LinkedIn, X (6k+ followers)

Rebecca Robbins - The New York Times (New York, NY) 

Rebecca is a pharmaceutical industry reporter at The New York Times, covering drug pricing, vaccine distribution and the business decisions of major healthcare companies. 

With years of experience, including at STAT, she examines drug affordability, safety and regulatory challenges, offering sharp insights into how these issues impact public health. 

Contact: LinkedIn, X (22k+ followers) 

John D. Carroll - Endpoints News (Dorset, Vermont) 

John is the co-founder and editor of Endpoints News, a go-to source for biotech and pharmaceutical industry news. With over 15 years covering biopharma, he tracks industry trends, funding challenges and major R&D developments.  

Carroll is also known for leading the Endpoints 11 list of top startups and moderating key industry discussions. His report offers sharp insights into the business and science of drug development. 

Contact: LinkedIn, X (70k followers) 
 

Sydney Lupkin - National Public Radio (NPR) (Washington, DC) 

Sydney is NPR’s pharmaceuticals correspondent, covering drug pricing, regulations and public health. Recently, she reported on the halt of cheaper obesity drug alternatives, the impact on patients and key takeaways from the Senate hearing for the new FDA commissioner nominee.  

Her stories focus on major pharmaceutical changes and their effects on people. 

Contact: LinkedIn, X (4k+ followers) 

 

Luke Timmerman - Timmerman Report (TR) (Seattle, WA) 

Luke is the founder of Timmerman Report, a must-read biotech newsletter covering industry trends, breakthroughs and leadership. A veteran journalist with a deep understanding of biotech’s business and science, he has written for Forbes and Bloomberg and was named one of the 100 most influential people in biotech by Scientific American.  

His reporting provides sharp insights into drug development, venture funding and biotech innovation. 

Contact: LinkedIn, X (34k+ followers) 
 

Emily Mullin - WIRED Magazine (Washington, DC) 

Emily is a staff writer at WIRED, focusing on biotechnology. Her recent articles cover a range of topics, including Neuralink's trademark filing for ‘Telepathy', the impact of drugs like Ozempic on libido and the potential of muscle implants to enable mind-controlled prosthetics without brain surgery.  

She has also reported on the mysterious developments in the bird flu outbreak and the rollout of the first CRISPR-based treatments to patients. 

Contact: LinkedIn, X (14k+ followers) 

 
Desiree Aberle - Deutsche Apotheker Zeitung (Stuttgart, Germany) 

Desiree is a pharmacist and editor at the Deutsche Apotheker Zeitung (DAZ). Her recent articles have explored topics such as the potential of omega-3 fatty acids to slow lung function decline, the role of choline during pregnancy and the efficacy of SSRIs in treating premenstrual dysphoric disorder. 

Contact: Linkedin 
 

Virginie Bagouet - APM News (UK) 

Virginie is a health journalist at Agence de Presse Médicale (APM) International in Paris, covering medical research and treatments. Her recent work explores topics like hepatitis B cures, advanced cervical cancer therapies and the impact of asymptomatic celiac disease.  

She provides in-depth insights into healthcare advancements and their real-world implications. 

Contact: LinkedIn, X (3k+ followers) 
 

Sarah Anderson, PhD - Drug Discovery News (Vancouver, Canada) 

Sarah is an assistant editor at Drug Discovery News (DDN). She has written for Discover Magazine, Astronomy Magazine and Chicago Health Magazine. Through her work, she highlights cutting-edge research in healthcare and biotech. 

Her recent articles cover medical advancements, including frostbite prevention creams, early detection of kidney transplant rejection and next-gen contact lenses for dry eye. 

Contact: LinkedIn, X 

 

Unlock Expanded Reach and Coverage with Our Media Contacts Database

Of course, this is just a small sample. Our global media database includes nearly 1,700+ biotech and pharmaceutical journalists - plus hundreds of thousands more across industries like tech, finance, AI and healthcare.

If you're looking to expand your usual media list to find contacts across industries, regions and segments, we’ve got the connections you need.    

Request a demo today to see our database in action! 

 

10 Popular Journalists Covering Biotech and Pharmaceuticals
10 Popular Journalists Covering Biotech and Pharmaceuticals

10 Popular Journalists Covering Biotech and Pharmaceuticals

Apr 10, 2025 2:58:39 PM 3 min read
The Risks of Using Outdated Media Lists
The Risks of Using Outdated Media Lists

The Risks of Using Outdated Media Lists

Apr 8, 2025 6:40:21 PM 2 min read
How Green Landscaping Group Engaged Investors with a Capital Markets Day
How Green Landscaping Group Engaged Investors with a Capital Markets Day

How Green Landscaping Group Engaged Investors with a Capital Markets Day

Apr 4, 2025 6:49:35 PM 2 min read

 

Subscribe by email